Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2013 | 05-2013 | 02-2013 | 11-2012 | 08-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 160 | -2,190 | -5,135 | 17,660 | 25,603 |
| Depreciation Amortization | 13,603 | 9,071 | 4,511 | 21,090 | 15,065 |
| Income taxes - deferred | -1,414 | -1,426 | -555 | -2,541 | 171 |
| Accounts receivable | 5,337 | 12,672 | 34,069 | 67,825 | 57,537 |
| Accounts payable and accrued liabilities | 5,268 | 10,410 | -10,057 | -86,571 | -63,823 |
| Other Working Capital | 22,402 | 29,244 | 37,552 | -19,375 | -41,012 |
| Other Operating Activity | -8,707 | -22,410 | -22,480 | 27,645 | 12,517 |
| Operating Cash Flow | $36,649 | $35,371 | $37,905 | $25,733 | $6,058 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,235 | -8,221 | -4,685 | -15,212 | -15,068 |
| Purchase Sale Intangibles | N/A | -1,355 | -1,300 | -3,500 | N/A |
| Other Investing Activity | 0 | -1,355 | -1,300 | -3,500 | 0 |
| Investing Cash Flow | $-14,235 | $-9,576 | $-5,985 | $-18,712 | $-15,068 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 661 | 661 |
| Common Stock Repurchased | N/A | N/A | N/A | -13,600 | -13,600 |
| Dividend Paid | -60,172 | -58,105 | -56,271 | -9,538 | -7,504 |
| Financing Cash Flow | $-60,172 | $-58,105 | $-56,271 | $-22,477 | $-20,443 |
| Beginning Cash Position | 117,174 | 117,174 | 117,174 | 132,630 | 132,630 |
| End Cash Position | 79,416 | 84,864 | 92,823 | 117,174 | 103,177 |
| Net Cash Flow | $-37,758 | $-32,310 | $-24,351 | $-15,456 | $-29,453 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,649 | 35,371 | 37,905 | 25,733 | 6,058 |
| Capital Expenditure | -12,880 | -8,221 | -4,685 | -15,212 | -11,568 |
| Free Cash Flow | 23,769 | 27,150 | 33,220 | 10,521 | -5,510 |